Michael W N Deininger Selected Research

ruxolitinib

1/2017	Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.
4/2015	Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I.
12/2013	Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael W N Deininger Research Topics

Disease

41	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2023 - 03/2002
10	Philadelphia Chromosome 12/2019 - 03/2003
6	Leukemia 12/2019 - 12/2003
6	Primary Myelofibrosis (Myelosclerosis) 01/2017 - 11/2005
6	Blast Crisis (Blast Phase) 12/2006 - 05/2002
5	Disease Progression 01/2017 - 03/2002
5	Neoplasms (Cancer) 11/2009 - 07/2005
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 11/2004
3	Chromosome Aberrations (Chromosome Abnormalities) 10/2007 - 03/2003
3	Systemic Mastocytosis 01/2006 - 12/2004
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2005 - 02/2004
2	Fatigue 01/2021 - 01/2017
2	Diarrhea 01/2021 - 01/2017
2	Pancreatitis 12/2019 - 11/2012
2	Essential Thrombocythemia 01/2017 - 11/2005
2	Polycythemia Vera 01/2017 - 11/2005
2	Splenomegaly 01/2017 - 04/2015
2	Genetic Translocation (Chromosomal Translocation) 09/2010 - 06/2004
1	Pneumonia (Pneumonitis) 01/2017
1	Sepsis (Septicemia) 01/2017
1	Anemia 04/2015
1	Thrombocytopenia (Thrombopenia) 04/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2012
1	Polycythemia (Erythrocytosis) 12/2006
1	Thrombocytosis (Thrombocythemia) 12/2006
1	Seminoma 01/2006
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 11/2005
1	Residual Neoplasm 03/2005
1	Myeloid Leukemia (Leukemia, Myelocytic) 04/2003
1	Cytopenia 05/2002

Drug/Important Bio-Agent (IBA)

30	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 03/2002
15	Phosphotransferases (Kinase)IBA 12/2019 - 11/2004
7	Tyrosine Kinase InhibitorsIBA 12/2023 - 11/2012
7	bcr-abl Fusion ProteinsIBA 12/2006 - 03/2002
5	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2010 - 03/2003
3	ruxolitinibIBA 01/2017 - 12/2013
3	Janus Kinase 1IBA 01/2017 - 12/2013
3	Janus Kinase 2IBA 01/2017 - 11/2005
3	ponatinibIBA 11/2012 - 11/2009
3	Dasatinib (BMS 354825)FDA Link 01/2011 - 01/2006
3	Proteins (Proteins, Gene)FDA Link 09/2010 - 09/2003
3	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2006 - 03/2003
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2005 - 11/2004
2	Lipase (Acid Lipase)FDA Link 12/2019 - 11/2012
2	DCC-2036IBA 05/2011 - 01/2011
2	nilotinib FDA Link 01/2011 - 11/2009
2	RNA (Ribonucleic Acid)IBA 09/2009 - 10/2007
2	Interferon-alpha (Interferon Alfa)IBA 12/2006 - 04/2003
2	Tyrosine (L-Tyrosine)FDA Link 11/2005 - 11/2004
1	asciminibIBA 12/2019
1	Adenosine Triphosphate (ATP)IBA 12/2019
1	AnticoagulantsIBA 01/2018
1	Heparin (Liquaemin)FDA LinkGeneric 01/2018
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 01/2017
1	Amylases FDA Link 11/2012
1	Amino Acids FDA Link 02/2009
1	Protein Isoforms (Isoforms)IBA 01/2006
1	Codon (Codons)IBA 01/2006
1	AP23464IBA 07/2005
1	AP23848IBA 07/2005
1	fms-Like Tyrosine Kinase 3IBA 11/2004
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2004
1	tandutinibIBA 11/2004
1	Oncogene Proteins (Oncogene Protein)IBA 06/2004
1	Proto-Oncogene Proteins c-cblIBA 12/2003
1	InterferonsIBA 04/2003
1	multidrug resistance-associated protein 1IBA 03/2003
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 03/2003

Therapy/Procedure

18	Therapeutics 01/2018 - 05/2002
2	Drug Therapy (Chemotherapy) 01/2018 - 09/2003
2	Transplantation 12/2006 - 12/2003
1	Complementary Therapies (Alternative Medicine) 09/2009